| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.22 | 0.0004 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |